Premium
Aerosolized ribavirin: the most expensive drug for pneumonia
Author(s) -
Chemaly R.F.,
Aitken S.L.,
Wolfe C.R.,
Jain R.,
Boeckh M.J.
Publication year - 2016
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1111/tid.12551
Subject(s) - medicine , ribavirin , intensive care medicine , pneumonia , scrutiny , aerosolization , drug , immunology , pharmacology , virus , anesthesia , hepatitis c virus , political science , law , inhalation
Dramatic, overnight cost increases of important orphan and generic medications have recently come under public and government scrutiny. We highlight the case of aerosolized ribavirin, an important antiviral agent in hematopoietic stem cell transplantation which, because of substantial price increases, may now cost more than the transplant procedure itself.